【レポートの概要(一部)】
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Introduction of technological advancements
3.1.1.2 Increasing demand for point of care facilities
3.1.1.3 Growing prevalence of target diseases
3.1.1.4 External funding for executing research and development exercises
3.1.2 Market Restraint Analysis
3.1.2.1 Presence of ambiguous regulatory framework
3.1.2.2 High prices of IVD diagnostic tests
3.2 Penetration & growth prospect mapping
3.3 Molecular Diagnostics – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis
4.1 Molecular diagnostics market: Product movement analysis
4.2 Instruments
4.2.1 Instruments market, 2013 – 2024 (USD Million)
4.3 Reagents
4.3.1 Reagents market, 2013 – 2024 (USD Million)
4.4 Others
4.4.1 Others market, 2013 – 2024 (USD Million)
Chapter 5 Market Categorization 2: Test Location Estimates & Trend Analysis
5.1 Molecular diagnostics market: Test Location movement analysis
5.2 Point of Care (PoC)
5.2.1 PoC market, 2013 – 2024 (USD Million)
5.3 Self Test or Over The Counter (OTC)
5.3.1 Self Test or OTC market, 2013 – 2024 (USD Million)
5.4 Central Laboratories
5.4.1 Central laboratories market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 3: Technology Estimates & Trend Analysis
6.1 Molecular diagnostics market: Technology movement analysis
6.2 Polymerase Chain Reaction (PCR)
6.2.1 PCR market, 2013 – 2024 (USD Million)
6.2.2 Multiplex PCR market, 2013 – 2024 (USD Million)
6.2.3 Other PCR market, 2013 – 2024 (USD Million)
6.3 In Situ Hybridization
6.3.1 In Situ Hybridization market, 2013 – 2024 (USD Million)
6.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4.1 INAAT market, 2013 – 2024 (USD Million)
6.5 Chips and Microarrays
6.5.1 Chips and microarrays market, 2013 – 2024 (USD Million)
6.6 Mass Spectrometry
6.6.1 Mass spectrometry market, 2013 – 2024 (USD Million)
6.7 Sequencing
6.7.1 Sequencing market, 2013 – 2024 (USD Million)
6.8 Transcription Mediated Amplification (TMA)
6.8.1 TMA market, 2013 – 2024 (USD Million)
6.9 Others
6.9.1 Others market, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 4: Application Estimates & Trend Analysis
7.1 Molecular diagnostics market: Application movement analysis
7.2 Oncology
7.2.1 Oncology market, 2013 – 2024 (USD Million)
7.2.2 Breast Cancer market, 2013 – 2024 (USD Million)
7.2.3 Prostate Cancer market, 2013 – 2024 (USD Million)
7.2.4 Colorectal Cancer market, 2013 – 2024 (USD Million)
7.2.5 Cervical Cancer market, 2013 – 2024 (USD Million)
7.2.6 Kidney Cancer market, 2013 – 2024 (USD Million)
7.2.7 Liver Cancer market, 2013 – 2024 (USD Million)
7.2.8 Blood Cancer market, 2013 – 2024 (USD Million)
7.2.9 Lung Cancer market, 2013 – 2024 (USD Million)
7.2.10 Others market, 2013 – 2024 (USD Million)
7.3 Pharmacogenomics
7.3.1 Pharmacogenomics market, 2013 – 2024 (USD Million)
7.4 Infectious Diseases
7.4.1 Infectious diseases market, 2013 – 2024 (USD Million)
7.4.2 Methicillin-resistant Staphylococcus Aureus (MRSA) market, 2013 – 2024 (USD Million)
7.4.3 Clostridium difficile market, 2013 – 2024 (USD Million)
7.4.4 Vancomycin-resistant enterococci market, 2013 – 2024 (USD Million)
7.4.5 Carbapenem-resistant bacteria market, 2013 – 2024 (USD Million)
7.4.6 Flu market, 2013 – 2024 (USD Million)
7.4.7 Respiratory syncytial virus (RSV) market, 2013 – 2024 (USD Million)
7.4.8 Candida market, 2013 – 2024 (USD Million)
7.4.9 Tuberculosis and drug-resistant TB market, 2013 – 2024 (USD Million)
7.4.10 Meningitis market, 2013 – 2024 (USD Million)
7.4.11 Gastrointestinal panel market, 2013 – 2024 (USD Million)
7.4.12 Chlamydia market, 2013 – 2024 (USD Million)
7.4.13 Gonorrhea market, 2013 – 2024 (USD Million)
7.4.14 HIV market, 2013 – 2024 (USD Million)
7.4.15 Hepatitis C market, 2013 – 2024 (USD Million)
7.4.16 Hepatitis B market, 2013 – 2024 (USD Million)
7.4.17 Others market, 2013 – 2024 (USD Million)
7.5 Genetic testing
7.5.1 Genetic testing market, 2013 – 2024 (USD Million)
7.5.2 Newborn screening market, 2013 – 2024 (USD Million)
7.5.3 Predictive and presymptomatic testing market, 2013 – 2024 (USD Million)
7.5.4 Other market, 2013 – 2024 (USD Million)
7.6 Neurological diseases
7.6.1 Neurological diseases market, 2013 – 2024 (USD Million)
7.7 Cardiovascular diseases
7.7.1 Cardiovascular diseases market, 2013 – 2024 (USD Million)
7.8 Microbiology
7.8.1 Microbiology market, 2013 – 2024 (USD Million)
Chapter 8 Market Categorization 5: Regional Estimates & Trend Analysis, by Product, Test Location, Technology & Application
8.1 Molecular diagnostics market share by region, 2013 & 2024
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 UK
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Belgium
8.3.7 Switzerland
8.3.8 Netherlands
8.3.9 Poland
8.3.10 Austria
8.3.11 Greece
8.3.12 Sweden
8.3.13 Turkey
8.3.14 Finland
8.4 Asia Pacific
8.4.1 India
8.4.2 China
8.4.3 Japan
8.4.4 Sri Lanka
8.4.5 Malaysia
8.4.6 Australia
8.4.7 New Zealand
8.4.8 Thailand
8.4.9 Vietnam
8.4.10 Ireland
8.4.11 Singapore
8.5 Latin America
8.5.1 Mexico
8.5.2 Brazil
8.5.3 Chile
8.5.4 Peru
8.5.5 Colombia
8.5.6 Argentina
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Jordan
8.6.4 UAE
8.6.5 Qatar
8.6.6 Nigeria
8.6.7 Egypt
Chapter 9 Competitive Landscape
9.1 Strategy framework
9.2 Market participation categorization
9.3 Company Profiles
9.3.1 Abbott Molecular
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Alere, Inc.
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Bayer Healthcare AG
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 Becton, Dickinson and Company
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 bioMérieux SA
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 Bio-Rad Laboratories, Inc.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 Cepheid
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Dako
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Danaher Corporation
9.3.9.1 Company Overview
9.3.9.2 Beckman Coulter
9.3.9.3 Leica Biosystems
9.3.9.4 Financial Performance
9.3.9.5 Product Benchmarking
9.3.9.6 Strategic Initiatives
9.3.9.7 Strategic Initiatives of Beckman Coulter Inc.
9.3.9.8 Strategic Initiatives of Leica Biosystems
9.3.10 Hologic, Inc. (Gen Probe)
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 Johnson & Johnson Services, Inc.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Novartis AG (Grifols)
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
9.3.13 Qiagen
9.3.13.1 Company Overview
9.3.13.2 Financial Performance
9.3.13.3 Product Benchmarking
9.3.13.4 Strategic Initiatives
9.3.14 F. Hoffmann-La Roche Ltd
9.3.14.1 Company Overview
9.3.14.2 Financial Performance
9.3.14.3 Product Benchmarking
9.3.14.4 Strategic Initiatives
9.3.15 Siemens Healthcare GmbH
9.3.15.1 Company Overview
9.3.15.2 Financial Performance
9.3.15.3 Product Benchmarking
9.3.15.4 Strategic Initiatives
9.3.16 Sysmex Corporation
9.3.16.1 Company Overview
9.3.16.2 Financial Performance
9.3.16.3 Product Benchmarking
9.3.16.4 Strategic Initiatives
【レポート販売概要】
■ タイトル:分子診断の世界市場分析:製品別、テストロケーション別(Poc、中央検査室)、技術別(PCR、原位置ハイブリダイゼーション、INAAT、マイクロアレイ、MS、NGS、TMA))、用途別(腫瘍、乳がん、前立腺がん、子宮頸がん、薬理ゲノム学、感染症、MRSA、C。ディフィシル、バンコマイシン耐性腸球菌、カルバペネム耐性、インフルエンザ、RSV、カンジダ、結核、髄膜炎、GITテスト、クラミジア、淋病、HIV、HCV、HBV 、遺伝学、神経学、心臓血管)、セグメント予測■ 英文:Molecular Diagnostics Market Analysis By Product, By Test Location (Poc, Central Lab), By Technology (PCR, In-Situ Hybridization, INAAT, Microarrays, MS, NGS, TMA), By Application (Oncology, Breast, Prostate, Cervical, Pharmacogenomics, Infectious Diseases, MRSA, C.Difficile, Vancomycin-Resistant Enterococci, Carbapenem-Resistant, Flu, RSV, Candida, TB, Meningitis, GIT Testing, Chlamydia, Gonorrhea, HIV, HCV, HBV, Genetics, Neurological, Cardiovascular), And Segment Forecasts To 2024
■ 発行日:2016年9月13日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707558
■ 調査対象地域:グローバル
- 化学療法に伴う貧血:世界の臨床試験レビュー(2014年上半期)Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy Induced Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Anemia. It includes an overview of t …
- 冷凍レディミールの世界市場2019-2023About this market The increasing demand for frozen ready meals because of the growth in organized retailing will lead to the growing frozen ready meals market growth during the forecast period. Supermarkets, hypermarkets, convenience stores, and discount stores are key distribution and marketing centers for frozen ready meals. The growing demand for frozen ready meals from several economies includ …
- ハエ駆除用化学薬品の世界市場:種類別(殺幼虫剤&殺ダニ剤)、廃棄物処理方法別(機械的生物学的処理、焼却、嫌気性消化)、適用方法別(毒性餌、ジクロロス気化器、屋外噴霧、殺幼虫剤噴霧器、その他)The fly control chemicals market for waste management accounted for $74.4 billion in 2018 and is anticipated to reach $120.9 billion by 2026, registering a CAGR of 6.1% from 2019 to 2026. Waste management is a systematic procedure of treating waste, comprising numerous activities such as collecting, transportation, and treatment (mechanical/ biological/ chemical). The growth of the market is drive …
- 世界の潜水艦及びMRO市場:競争状況及び戦略的インサイトSummary This report shows the leading Global Submarine and MRO market segments in various regions across the world. Details of top companies active across the global Global Submarine and MRO market are provided, together with market size and forecast 2013-2023 for the main players across those areas. Key Findings The report provides a detailed analysis of the competitive landscape of the Global Su …
- 世界の放電加工機市場2015The Global Electrical Discharge Machines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electrical Discharge Machines industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electrical Discharge Machines market analysis is provided for the internationa …
- クラウド基盤のモバイル付加価サービス(VAS):セキュリティ課題、市場機会、予測2013-2018(Mobile Value-added Services (VAS) in the Cloud: Security Challenges, Market Opportunities and Forecasts 2013 – 2018)Cloud computing has started to play a crucial role in mobile based value-added service (VAS) offering as end-users appetite for applications is ever-increasing and service providers are increasingly moving towards alternative service platforms and support infrastructure. Mobile VAS in the Cloud includes communications, content, commerce and applications of various types. Leading companies are posi …
- 通信産業向けセキュリティソフトウェアの世界市場About security services Security software comprise a suite of security products. Their scope encompasses several areas such as data protection, compliance, architecture, email security, web security, governance, data loss prevention, security information and event management, and identity and access. A security software solution provides several features such as encryption, endpoint monitoring, id …
- 世界のMeat市場:M&A動向(2014年4月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global meat market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global meat market throughout the month. Additionally, the report provides an overview of all the partnering, alli …
- Myopia:グローバル臨床試験レビューH2, 2013Myopia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2013" provides data on the Myopia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myopia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 世界のベーカリー及びシリアル市場のニュース及びイベント動向(2014年6月)Synopsis The report provides a review of the latest news and key events in the global bakery & cereals market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global bakery & cereals market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in …
- Pengrowth Energy Corporation:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- N-methyl-pyrrolidoneの世界市場N-methyl-pyrrolidone(NMP) (CAS 872-50-4) Market Research Report 2012 presents comprehensive data on n-methyl-pyrrolidone(nmp) markets globally and regionally (Europe, Asia, North America etc.) The report includes n-methyl-pyrrolidone(nmp) description, covers its application areas and related patterns. It overviews n-methyl-pyrrolidone(nmp) market, names n-methyl-pyrrolidone(nmp) producers and indi …
- データサイエンスプラットフォームの世界市場予測(~2021年)“Advancement in big data technologies is one of the drivers for the growth of the data science platform analytics market”The data science platform market size is estimated to grow from USD 19.58 billion in 2016 to USD 101.37 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 38.9%. Enterprises are focusing on methods enabling simpler use of data to drive their business and advancement in …
- 圧力モニタリングの世界市場分析:製品別(血圧、肺圧、眼内圧、頭蓋内圧)、手順別(非侵襲性、侵襲性)、用途別、エンドユーザー別、セグメント予測、2014-2025The global pressure monitoring market is expected to reach USD 11.9 billion by 2025, according to a new report by Grand View Research, Inc. Pressure fluctuations in vital parts of the body often lead to chronic diseases such as glaucoma, cardiac disorders, and respiratory disorders. This has led to high demand for pressure monitoring devices.According to the American Heart Association, 77.9 millio …
- けいそう土の世界市場Diatomaceous Earth (CAS 61790-53-2) Market Research Report 2014 presents comprehensive data on diatomaceous earth markets globally and regionally (Europe, Asia, North America etc.) The report includes diatomaceous earth description, covers its application areas and related patterns. It overviews diatomaceous earth market, names diatomaceous earth producers and indicates its suppliers. Besides, the …